ALLMedicine™ Anthrax Center

Jan 20th, 2022 - The intentional use of Bacillus anthracis in 2001 as a bioterrorism weapon with fatal consequences renewed interest in past epidemiologic and animal research about pathogenesis and posed new dilemmas about diagnosis and treatment. Cases in the Oct...

Jan 18th, 2022 - This is a randomized, parallel-group, double-blind, Phase 1 study designed to assess safety, tolerability and immunogenicity of 2 formulations of adjuvanted anthrax vaccine (AV7909), lyophilized and liquid. Forty healthy young adults, 18 to 45 yea...

Jan 18th, 2022 - This field study is a post-marketing requirement from the FDA to evaluate the clinical benefit (course of illness and survival), safety and pharmacokinetics of obiltoxaximab administered to patients as part of their medical care for treatment or p...

Jan 16th, 2022 - This study is a baseline survey to assess the knowledge, attitude and practices with regards to the anthrax disease among the communities before demonstrating a One Health approach for elimination of human anthrax in an endemic district of Odisha....

Jan 9th, 2022 - Lethal toxin (LeTx)-mediated killing of myeloid cells is essential for Bacillus anthracis, the causative agent of anthrax, to establish systemic infection and induce lethal anthrax. The "LeTx-sensitive" NLRP1b inflammasome of BALB/c and 129S macro...

Dec 14th, 2019 - This report updates the 2009 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding use of anthrax vaccine in the United States (Wright JG, Quinn CP, Shadomy S, Messonnier N. Use of anthrax vaccine in the United...

Jul 24th, 2010 - These recommendations from the Advisory Committee on Immunization Practices (ACIP) update the previous recommendations for anthrax vaccine adsorbed (AVA) (CDC. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee ...

Jan 20th, 2022 - The intentional use of Bacillus anthracis in 2001 as a bioterrorism weapon with fatal consequences renewed interest in past epidemiologic and animal research about pathogenesis and posed new dilemmas about diagnosis and treatment. Cases in the Oct...

Jan 18th, 2022 - This is a randomized, parallel-group, double-blind, Phase 1 study designed to assess safety, tolerability and immunogenicity of 2 formulations of adjuvanted anthrax vaccine (AV7909), lyophilized and liquid. Forty healthy young adults, 18 to 45 yea...

Jan 18th, 2022 - This field study is a post-marketing requirement from the FDA to evaluate the clinical benefit (course of illness and survival), safety and pharmacokinetics of obiltoxaximab administered to patients as part of their medical care for treatment or p...

Feb 2nd, 2021 - This study will use a convenience sample and passive referral to enroll participants. For the maternal outcome portion of the study, pregnant active duty women who consent to join the registry are expected to complete several surveys over the cour...

Nov 29th, 2018 - This is an open-label study to evaluate the immunogenicity and safety of raxibacumab in healthy adult male and female subjects. Subjects who have received raxibacumab >= 4 months ago will be enrolled and dosed as follows: A maximum of 25 subjects ...

Jan 20th, 2022 - Some of the world's deadliest microbes are proving no match for a new sustainable disinfectant made from sawdust and water, according to researchers who were looking for environmentally friendly alternatives to chlorine cleaning products. What to ...

Aug 6th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. SAN DIEGO (AP) — Since President Joe Biden asked the Pentagon last week to look at adding the COVID-19 vaccine to the military's mandatory shots, ...

Jun 16th, 2021 - Medscape's Medical Power Couples is a new series highlighting spouses or domestic partners prominent in healthcare. Both have achieved high-level professional success and have made significant contributions to their respective fields. Carlos del R...

Jun 16th, 2021 - Medscape's Medical Power Couples is a new series highlighting spouses or domestic partners prominent in healthcare. Both have achieved high-level professional success and have made significant contributions to their respective fields. Carlos del R...

Apr 15th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. AIDS activists hold a demonstration outside the FDA headquarters on October 11, 1988, demanding access to experimental treatment. These efforts he...